JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A4357 Dorzolamide HCl

Summary: Carbonic anhydrase inhibitor

insoluble in EtOH; ≥13 mg/mL
A4371 Ferrostatin-1 (Fer-1)
57 Citation

Target: Ferroptosis

Summary: ferroptosis inhibitor

≥149 mg/mL
A4393 Paclitaxel (Taxol)
27 Citation

Target: Microtubules/Tubulins

Summary: microtubule depolymerization inhibitor

≥85.6 mg/mL
A4472 Mdivi 1
1 Citation

Summary: Selective DRP1/Dnm1 inhibitor, cell-permeable

insoluble in H2O; insoluble in EtOH; ≥17.65 mg/mL
A8183 Trichostatin A (TSA)
30 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; ≥15.12 mg/mL
A8176 Apicidin
3 Citation

Target: Histone Deacetylases (HDACs)

Summary: Potent HDAC inhibitor

soluble in DMSO or ethanol
A8212 PR-619

Target: Deubiquitinating enzymes (DUBs)

Summary: Deubiquitylating enzymes (DBUs) inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
A8222 BX795
2 Citation

Summary: PDK1 inhibitor

≥59.1 mg/mL
A8254 SB 203580
38 Citation

Target: p38|PKB

Summary: P38 MAP kinase inhibitor

insoluble in H2O; ≥18.872 mg/mL
A8214 AZD8055
7 Citation

Target: mTOR

Summary: MTOR inhibitor

≥23.3 mg/mL